Keyphrases
Neuroblastoma
100%
Nuclear Imaging
100%
123I-MIBG
66%
Positron Emission Tomography
33%
Nuclear Medicine
33%
Single-photon Emission Computed Tomography (SPECT)
33%
Working Diagnosis
16%
Refractory Disease
16%
High Risk
16%
Metastatic Disease
16%
Poor Prognosis
16%
Treatment Strategy
16%
Imaging Techniques
16%
Recurrent Disease
16%
Solid Malignancies
16%
Computed Tomography
16%
Diagnostic Accuracy
16%
Response Assessment
16%
18F-fluorodeoxyglucose (18F-FDG)
16%
Whole-body
16%
Radiotracer
16%
Use Characteristics
16%
Extracranial
16%
124I
16%
Extent of Disease
16%
DOTA-peptides
16%
Low Spatial Resolution
16%
Small Lesions
16%
New Tracer
16%
123I
16%
Whole-body Scintigraphy
16%
Accurate Method
16%
18F-DOPA
16%
Gallium-68
16%
Medicine and Dentistry
Ganglioneuroblastoma
100%
Nuclear Medicine
100%
Iodine 123
50%
Positron Emission Tomography
33%
Fluorine-18
33%
Radioactive Tracer
33%
Single-Photon Emission Computed Tomography
33%
Cancer
16%
Disease
16%
Metastatic Carcinoma
16%
Recurrent Disease
16%
Computer Assisted Tomography
16%
Diagnostic Accuracy
16%
Gallium 68
16%
Fluorodeoxyglucose F 18
16%
Imaging Technique
16%
Whole Body Scintiscanning
16%
Carbon 11
16%
Iodine 124
16%
Tetraxetan
16%
DOPA
16%
Nuclear Imaging
16%